{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:13:35Z","timestamp":1788488015991,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,8,20]],"date-time":"2017-08-20T00:00:00Z","timestamp":1503187200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LZ16H160002"],"award-info":[{"award-number":["LZ16H160002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zhejiang Provincial Program for Cultivation of High-level Innovative Health Talents"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s10549-017-4425-z","type":"journal-article","created":{"date-parts":[[2017,8,20]],"date-time":"2017-08-20T11:46:08Z","timestamp":1503229568000},"page":"865-873","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Germline mutations of PALB2 gene in a sequential series of Chinese patients with breast cancer"],"prefix":"10.1007","volume":"166","author":[{"given":"Kun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JieKai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2263-6275","authenticated-orcid":false,"given":"Yiding","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,20]]},"reference":[{"issue":"6","key":"4425_CR1","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.molcel.2006.05.022","volume":"22","author":"B Xia","year":"2006","unstructured":"Xia B, Sheng Q, Nakanishi K, Ohashi A, Wu J, Christ N, Liu X, Jasin M, Couch FJ, Livingston DM (2006) Control of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2. Mol Cell 22(6):719\u2013729","journal-title":"Mol Cell"},{"issue":"27","key":"4425_CR2","doi-asserted-by":"crossref","first-page":"18302","DOI":"10.1074\/jbc.M109.016717","volume":"284","author":"SMH Sy","year":"2009","unstructured":"Sy SMH, Huen MSY, Zhu Y, Chen J (2009) PALB2 Regulates Recombinational Repair through Chromatin Association and Oligomerization. J Biol Chem 284(27):18302\u201318310","journal-title":"J Biol Chem"},{"issue":"6","key":"4425_CR3","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.cub.2009.02.018","volume":"19","author":"F Zhang","year":"2009","unstructured":"Zhang F, Ma J, Wu J, Ye L, Cai H, Xia B, Yu X (2009) PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response. Current Biol 19(6):524\u2013529","journal-title":"Current Biol"},{"issue":"2","key":"4425_CR4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ng1959","volume":"39","author":"N Rahman","year":"2006","unstructured":"Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, Reid S, Spanova K, Barfoot R, Chagtai T et al (2006) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nature Genet 39(2):165\u2013167","journal-title":"Nature Genet"},{"issue":"7133","key":"4425_CR5","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nature05609","volume":"446","author":"H Erkko","year":"2007","unstructured":"Erkko H, Xia B, Nikkil\u00e4 J, Schleutker J, Syrj\u00e4koski K, Mannermaa A, Kallioniemi A, Pylk\u00e4s K, Karppinen S-M, Rapakko K et al (2007) A recurrent mutation in PALB2 in Finnish cancer families. Nature 446(7133):316\u2013319","journal-title":"Nature"},{"issue":"6","key":"4425_CR6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa1400382","volume":"371","author":"AC Antoniou","year":"2014","unstructured":"Antoniou AC, Casadei S, Heikkinen T, Barrowdale D, Pylkas K, Roberts J, Lee A, Subramanian D, De Leeneer K, Fostira F et al (2014) Breast-cancer risk in families with mutations in PALB2. New Eng J Med 371(6):497\u2013506","journal-title":"New Eng J Med"},{"issue":"13","key":"4425_CR7","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1200\/JCO.2015.65.0747","volume":"34","author":"N Tung","year":"2016","unstructured":"Tung N, Lin NU, Kidd J, Allen BA, Singh N, Wenstrup RJ, Hartman AR, Winer EP, Garber JE (2016) Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer. J Clin Oncol 34(13):1460\u20131468","journal-title":"J Clin Oncol"},{"issue":"6","key":"4425_CR8","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1158\/0008-5472.CAN-10-3958","volume":"71","author":"S Casadei","year":"2011","unstructured":"Casadei S, Norquist BM, Walsh T, Stray S, Mandell JB, Lee MK, Stamatoyannopoulos JA, King MC (2011) Contribution of Inherited Mutations in the BRCA2-Interacting Protein PALB2 to Familial Breast Cancer. Cancer Res 71(6):2222\u20132229","journal-title":"Cancer Res"},{"issue":"1","key":"4425_CR9","doi-asserted-by":"crossref","first-page":"R17","DOI":"10.1186\/bcr3392","volume":"15","author":"Z Teo","year":"2013","unstructured":"Teo Z, Park D, Provenzano E, Chatfield C, Odefrey F, Nguyen-Dumont T, Dowty J, Hopper JL, Goldgar DE, Southey MC (2013) Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families. Breast Cancer Res Treat 15(1):R17","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"4425_CR10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10689-013-9620-4","volume":"12","author":"ZL Teo","year":"2013","unstructured":"Teo ZL, Sawyer SD, James PA, Mitchell G, Trainer AH, Lindeman GJ, Shackleton K, Cicciarelli L, Southey MC (2013) The incidence of PALB2 c.3113G>A in women with a strong family history of breast and ovarian cancer attending familial cancer centres in Australia. Fam Cancer 12(4):587\u2013595","journal-title":"Fam Cancer"},{"issue":"6","key":"4425_CR11","doi-asserted-by":"crossref","first-page":"R109","DOI":"10.1186\/bcr2796","volume":"12","author":"M Southey","year":"2010","unstructured":"Southey M, Teo Z, Dowty J, Odefrey F, Park D, Tischkowitz M, Sabbaghian N, Apicella C, Byrnes G, Winship I et al (2010) A PALB2 mutation associated with high risk of breast cancer. Breast Cancer Res Treat 12(6):R109","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"4425_CR12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10549-008-0036-z","volume":"114","author":"AY Cao","year":"2008","unstructured":"Cao AY, Huang J, Hu Z, Li W-F, Ma Z-L, Tang L-L, Zhang B, Su F-X, Zhou J, Di G-H et al (2008) The prevalence of PALB2 germline mutations in BRCA1\/BRCA2 negative Chinese women with early onset breast cancer or affected relatives. Breast Cancer Res Treat 114(3):457\u2013462","journal-title":"Breast Cancer Res Treat"},{"key":"4425_CR13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40001-015-0182-9","volume":"20","author":"YT Li","year":"2015","unstructured":"Li YT, Jiang WH, Wang XW, Zhang MS, Zhang CG, Yi LN, WuwaliKhan F, Ayoufu A, Ou JH (2015) PALB2 mutations in breast cancer patients from a multi-ethnic region in northwest China. Eur J Med Res 20:85","journal-title":"Eur J Med Res"},{"issue":"6","key":"4425_CR14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/bcr1828","volume":"9","author":"WD Foulkes","year":"2007","unstructured":"Foulkes WD, Ghadirian P, Akbari MR, Hamel N, Giroux S, Sabbaghian N, Darnel A, Royer R, Poll A, Fafard E et al (2007) Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women. Breast Cancer Res 9(6):83","journal-title":"Breast Cancer Res"},{"key":"4425_CR15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13053-016-0049-2","volume":"14","author":"MC Southey","year":"2016","unstructured":"Southey MC, Winship I, Nguyen-Dumont T (2016) PALB2: research reaching to clinical outcomes for women with breast cancer. Hered Cancer Clin Pract 14:9","journal-title":"Hered Cancer Clin Pract"},{"key":"4425_CR16","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/TACG.S34116","volume":"6","author":"M Southey","year":"2013","unstructured":"Southey M (2013) Teo, Winship I: PALB2 and breast cancer: ready for clinical translation! Appl Clin Genet 6:43\u201352","journal-title":"Appl Clin Genet"},{"issue":"2","key":"4425_CR17","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10549-014-3260-8","volume":"149","author":"T Nguyen-Dumont","year":"2015","unstructured":"Nguyen-Dumont T, Hammet F, Mahmoodi M, Tsimiklis H, Teo ZL, Li R, Pope BJ, Terry MB, Buys SS, Daly M et al (2015) Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family Registry. Breast Cancer Res Treat 149(2):547\u2013554","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"4425_CR18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10549-016-4034-2","volume":"161","author":"H Kim","year":"2017","unstructured":"Kim H, Cho DY, Choi DH, Oh M, Shin I, Park W, Huh SJ, Nam SJ, Lee JE, Kim SW (2017) Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer. Breast Cancer Res Treat 161(1):95\u2013102","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-017-4425-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4425-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4425-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T05:05:48Z","timestamp":1510203948000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-017-4425-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,20]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["4425"],"URL":"https:\/\/doi.org\/10.1007\/s10549-017-4425-z","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,20]]}}}